ClinicalTrials.gov record
Completed Phase 2 Interventional

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

ClinicalTrials.gov ID: NCT00003662

Public ClinicalTrials.gov record NCT00003662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Adults and Children With Bone Marrow Failure Syndromes or Inherited Metabolic or Hematologic Diseases

Study identification

NCT ID
NCT00003662
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Roswell Park Cancer Institute
Other
Enrollment
90 participants

Conditions and interventions

Interventions

  • anti-thymocyte globulin Biological
  • busulfan Drug
  • cyclophosphamide Drug
  • cyclosporine Drug
  • melphalan Drug
  • methylprednisolone Drug
  • radiation therapy Radiation
  • umbilical cord blood transplantation Procedure

Biological · Drug · Radiation + 1 more

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 1998
Primary completion
Dec 31, 2000
Completion
Dec 31, 2000
Last update posted
Mar 6, 2011

1998 – 2001

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
University of Florida Health Science Center Gainesville Florida 32610-0296
Division of Pediatric Surgery Jacksonville Florida 32207
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612
Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois 60612
University of Chicago Cancer Research Center Chicago Illinois 60637
Children's Hospital of New Orleans New Orleans Louisiana 70118
Cardinal Glennon Children's Hospital St Louis Missouri 63104
Hackensack University Medical Center Hackensack New Jersey 07601
Roswell Park Cancer Institute Buffalo New York 14263-0001
New York Blood Center New York New York 10021
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134-1095
Medical University of South Carolina Charleston South Carolina 29425-0721
University of South Carolina School of Medicine Columbia South Carolina 29203

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2011 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003662 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →